Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3231 results

Sort By:

A Study of GM-XANTHO in Pressure Ulcer Patients

Study ID: NCT05199077
Start Date: 2026-09-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

GM-Blonde

Sponsor

Xantho Biotechnology Co., LTD

Source: clinicaltrials.gov

Share:
Add to list

What is the Feasibility of Narrative Exposure Therapy (NET) for People Experiencing Psychosis?

Study ID: NCT07237529
Start Date: 2025-12-15
End Date: 2026-11-16
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1

Intervention / Treatment

Narrative Exposure Therapy (NET)

Sponsor

University of Nottingham

Source: clinicaltrials.gov

Share:
Add to list

Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas

Study ID: NCT05253131
Start Date: 2025-12-15
End Date: 2031-12-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

41

Intervention / Treatment

Selumetinib

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

IMPACT OF DIFFERENT ELECTRICAL FREQUENCIES USED IN PERCUTANEOUS NEUROMODULATION ON MUSCLE STRENGTH AND PRESSURE PAIN THRESHOLDS

Study ID: NCT07269925
Start Date: 2026-02-15
End Date: 2026-07-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Percutaneous electrical nerve stimulation: High frequency

Percutaneous electrical nerve stimulation: Low frequency

Sponsor

Complutense University of Madrid

Source: clinicaltrials.gov

Share:
Add to list

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

Study ID: NCT07230691
Start Date: 2025-12-12
End Date: 2030-11-19
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

460

Intervention / Treatment
Sponsor

Janssen Research & Development, LLC

Source: clinicaltrials.gov

Share:
Add to list

HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking

Study ID: NCT07264582
Start Date: 2026-10-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

368

Intervention / Treatment

Sex Trafficking Survivor-Developed Digital Crowdsourced Intervention

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Transcutaneous Bilirubinometry and Phototherapy

Study ID: NCT04246229
Start Date: 2026-01-01
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

Transcutaneous bilirubinometry

Serum bilirubin

Sponsor

Princess Amalia Children's Clinic

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

Study ID: NCT07266831
Start Date: 2026-01-14
End Date: 2030-04-25
Study Type

Interventional

Study Phase

Phase3

No. of Participants

570

Intervention / Treatment

ISL

HEAD

BIC/FTC/TAF

Placebo for BIC/FTC/TAF

Placebo to ISL/ULO

ISL/HEAD

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Deucravacitinib-TNF Combination Therapy for Difficult-to-Control Psoriatic Disease

Study ID: NCT07280702
Start Date: 2025-12-15
End Date: 2027-12-15
Study Type

Interventional

Study Phase

Phase4

No. of Participants

128

Intervention / Treatment

Deucravacitinib

Placebo

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Home-based Vision Therapy

Study ID: NCT06886737
Start Date: 2026-02-02
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

45

Intervention / Treatment

Virtual-reality convergence training game

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list